The contemporaneous treatment with LBW242 and TRAIL increased the rate of apoptosis of ovarian cancer cells compared to the values observed when the cells were grown with TRAIL alone (p<0.05) or LBW242 alone (p<0.05). The gene discussed is TNFSF10; the disease is ovarian carcinoma.